Our team of process and analytical experts draw on their integrated understanding in both the development and manufacturing of the API and the formulation. This is of particular importance when it comes to the characterization of a molecular compl…

June 2020

Dr. Reddy’s Flow Chemistry experts, Srividya Ramakrishnan and Rakeshwar Bandichhor, recently participated in the panel discussion of Chemistry Today, where they shared their perspectives on flow technology and its potential to be…

Genotoxic impurities (GTIs) have recently challenged the pharmaceutical industry by virtue of their presence at a level of parts per million (ppm) in drug products, especially in high dosage molecules like Ranolazine, which has a prescribed maximu…

For more than two decades, Dr. Reddy's has been recognized as one of the largest manufacturers of H2 receptor antagonist APIs such as Famotidine and Nizatidine. Our Tidine APIs are used by formulation companies across Europe, US, Japan, Middle-Eas…

Our team of experts draw on their integrated understanding in the development and manufacturing of the Sitagliptin API and the formulation. This is of particular importance when it comes to particle engineering and powder flow characteristics whic…

Sugammadex Sodium is one of the key molecules in Dr. Reddy’s API portfolio and an ideal use case on how a thorough understanding of the interaction between API and formulation can lead to a successful formulation development. Read our latest white…

Manufacturer of APIs are now required to review their manufacturing processes and prove the absence of nitrosamine impurities. This whitepaper outlines the regulations and a case study on how Dr. Reddy’s Sartan API’s (such as Valsartan) already ad…